GRAY ZONE LYMPHOMA
Clinical trials for GRAY ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRAY ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for GRAY ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to tame aggressive lymphoma
Disease control Recruiting nowThis early-stage trial tests whether adding the targeted drug polatuzumab vedotin (with or without another drug, glofitamab) to standard chemotherapy is safe and tolerable for people with untreated, fast-growing B-cell lymphomas. About 56 participants will receive the combination…
Matched conditions: GRAY ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug combo offers hope for patients with stubborn lymphomas
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to the immunotherapy pembrolizumab is safe and effective for people with certain types of lymphoma that have come back or not responded to treatment. About 53 adults with Hodgkin or non-Hodgkin lymphoma will receive the combina…
Matched conditions: GRAY ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Seda S. Tolu • Aim: Disease control
Last updated May 13, 2026 15:58 UTC